November 21st, 2006
Herceptin® Advances Treatment of Early HER2-Positive Breast Cancer
The good news that Herceptin® (trastuzumab) (the world’s first targeted therapy) is now available for many women with early-stage HER2-positive breast cancer, marks a significant advancement in breast cancer management.
According to Edith Perez, M.D., director of Mayo Clinic’s Breast Clinic in Jacksonville, Florida:
“…signifies the importance for women who are newly diagnosed with breast cancer to […]
Recent Comments